CVS Caremark Corporation will pay $5 million to settle Federal Trade Commission charges that it misrepresented the prices of certain Medicare Part D prescription drugs – including drugs used to treat breast cancer symptoms and epilepsy – at CVS and Walgreens pharmacies. The allegedly deceptive claims caused many seniors and disabled consumers to pay significantly more [...]
Filed under: Compliance Enforcement Activities, Consumer Protection Alerts, FTC, FTC Enforcement Updates | Tagged: drug prices, Federal Trade Commission, healthcare costs, Medicare Part D, prescription drugs, price gouging | Leave a Comment »










